New cancer clinical trial: SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects

Published on: December 25, 2017 at 10:00AM
Conditions:   Non-small Cell Lung Cancer Stage II;   Non-small Cell Lung Cancer Stage I
Interventions:   Radiation: Stereotactic body radiotherapy;   Drug: Nivolumab
Sponsors:   Royal Marsden NHS Foundation Trust;   Bristol-Myers Squibb
Not yet recruiting
http://ift.tt/2DXqjzX